Skip to content

M.D.D. PHARMA

Active
Public limited companyfounded 198937 yrs activeAvenue Pasteur 2, 1300 Wavre, BelgiumKBO/BCE: BE 0437.759.119
Summary

M.D.D. PHARMA has been active since 1989 and the Belgian State Gazette contains no insolvency or warning signals. The 2026 annual accounts show equity of €565,871 and a net result of €370,209. Equity is growing by ~4.1% per year across the filed fiscal years. Its solvency ranks better than 15% of 254 sector peers (fiscal year 2026). The computed 12-month bankruptcy probability is 1.0% (low).

Risk analysisWatch ReportCompare
M.D.D. PHARMAActiveChecked score 66/100
Risk analysis ReportCompare

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730Warehousing and support activities for transportation NACE 52310
#7 employer in Wavre, Wholesale and retail trade sector1 site
Size
€28.6mturnover 2026
Staff
104.8 FTE
Equity
€565,871
Profit
€370,209
Financial health
66 Healthy Checked score 2026
Bankruptcy chance 12 m
1.0%
Structure
Parent
BENU · 100%
Board
6 members
Accounts 67 d early2 of 23 deeds read
Why 66- Equity €565,871 (4.6% of total assets)- Liquidity: current ratio 0.67, cash €19,800- Sector Retail trade (NACE 47)- Size: turnover €28.6m, 104.8 FTE, total assets €12.2mShow the evidence

Checked score

Score 2026
66 / 100
Healthy
Probability in this band: 0.55% to 1.5%
Better than 42% of its sector peers (NACE 47, medium-sized)
Performance against the sector, not lower risk
Every signal that weighs is under Signals.
Financial strength · tick = 2025
Weak
Solvency 30+3
equity 4.6% of total assets
Liquidity 0=
short-term debt 92.4% · cash 0.2%
Profitability 63-7
return on assets 3.0%
Bankruptcy probability, 12 months
1.0% Low
0%0.5%1.5%4%10%≥ 25%

About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.5% (388 companies)
Last 24 months 11-2024: 0.8% 12-2024: 0.8%● 0.0% vs 11-2024 01-2025: 0.8%● 0.0% vs 12-2024 02-2025: 0.8%● 0.0% vs 01-2025 03-2025: 0.7%▼ -3.4% vs 02-2025lowest value 04-2025: 0.7%▲ +1.4% vs 03-2025 05-2025: 0.8%▲ +4.3% vs 04-2025 06-2025: 0.8%▲ +0.5% vs 05-2025 07-2025: 0.8%▲ +2.2% vs 06-2025 08-2025: 0.8%▲ +0.8% vs 07-2025 09-2025: 0.8%● 0.0% vs 08-2025 10-2025: 0.8%● 0.0% vs 09-2025 11-2025: 0.8%● 0.0% vs 10-2025 12-2025: 0.8%● 0.0% vs 11-2025 01-2026: 0.8%● 0.0% vs 12-2025 02-2026: 0.8%● 0.0% vs 01-2026 03-2026: 0.8%▼ -3.4% vs 02-2026 04-2026: 0.8%▲ +1.4% vs 03-2026 05-2026: 0.8%▲ +1.8% vs 04-2026 06-2026: 0.8%● 0.0% vs 05-2026 07-2026: 1.0%▲ +23.6% vs 06-2026highest value 08-2026: 1.0%● 0.0% vs 07-2026highest value 09-2026: 1.0%● 0.0% vs 08-2026highest value 10-2026: 1.0%● 0.0% vs 09-2026highest value
  • Equity €565,871 (4.6% of total assets) raises the probability
  • Liquidity: current ratio 0.67, cash €19,800 raises the probability
  • Sector Retail trade (NACE 47) raises the probability
  • Size: turnover €28.6m, 104.8 FTE, total assets €12.2m raises the probability for this profile
Credit up to €35,000 at 30 days acceptable
Liquidity short (current ratio 0.67 against 0.67 in 2025; short-term debt: 92.4% and cash: 0.2% of total assets), and 95.4% of the assets are financed with debt.
How it is calculated

The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 47, medium-sized). Better than this share of them on solvency 15%, liquidity 2%, profitability 59%, growth against the median 91%. That is performance, not lower risk; the band itself always comes from the probability.

Bankruptcy probability: model pd-v3.202610021621, computed on 05-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.

Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Six signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Equity €565,871 (4.6% of total assets)
In the bankruptcy model this factor raises the probability.
NBB · annual accounts
raises risk · Liquidity: current ratio 0.67, cash €19,800
In the bankruptcy model this factor raises the probability.
NBB · annual accounts
raises risk · Sector Retail trade (NACE 47)
In the bankruptcy model this factor raises the probability.
KBO
raises risk · Size: turnover €28.6m, 104.8 FTE, total assets €12.2m
In the bankruptcy model this factor raises the probability for this profile.
NBB · annual accounts
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 15% of 254 sector peers (2026).
NBB · sector comparison
Position among 254 sector peers
Solvency
better than 15%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-01-2026 was due by 31-08-2026 and was filed on 25-06-2026, 67 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2026
67 d early
2025
51 d early
2024
53 d early
2023
28 d early
2022
32 d early
2021
44 d early
2020
9 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 41 days before the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-01-2027 and is due by 31-08-2027. Nothing is late today. Usually files around 10 July (3 of the last 3 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
06-10-2026 today31-01-2027 close31-08-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Reappointments: EvelineMaryns, ArnaudBerken and PhilippeLacroixState Gazette act
  2. Annual accounts filedfiscal year 2026 · full…
  3. Weakest financial yearnet €370,209 ▼55.1%

Key points

  • Positive: Equity rose in 2026from €195,662 to €565,871 ▲ 189% View
  • Caution: Among the weakest 16% on solvencysector median 35.5% · 254 companies 4.6% View
  • Positive: Always filed on timeaccounts within the deadline every year 8 years View
  • Positive: 8 profitable years in a rowprofit 2026: €370,209 8 years View
  • Controlled by BENUknown shareholders 100% 100% View

By topic

Financials

Fiscal year
2026
Turnover
€28.6m
Profit
€370,209
Solvency
4.6%
Turnover▲ 15.4%
Net result
20192026
Go to Financials

Timeline

Events
15
Since
2017
Next accounts
by 31-08-2027
  1. 10-07-2026Reappointments: EvelineMaryns, ArnaudBerken and PhilippeLacroix
  2. 25-06-2026Annual accounts filed
  3. 31-01-2026Weakest financial year
Go to Timeline

Company details

Sites
1
Legal form
Public limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
06-07-1989
Year ends
31-01
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Is the workforce growing, and do people stay?Employer check Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What other support did companies like this one receive, and it did not?Subsidies

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure